ArticleRadiation oncology journal2022

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients.

Christos Nanos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.